Antisense oligonucleotide-mediated exon 27 skipping restores dysferlin function in dysferlinopathy patient-derived muscle cellsSaeed Anwar, Toshifumi Yokota, Joshua J. A. Lee et al.|Molecular Therapy — Nucleic Acids|2024Cited by 2
eSkip2 prioritizes exon-skipping antisense oligonucleotide target regions across exon–intron contextsShuntaro Chiba, Yasushi Okuno, Katsuhiko Kunitake et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0